Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs

Value in Health - United Kingdom
doi 10.1016/j.jval.2019.10.010